Strange: Bullish SGMO Analysts Actually See -8.91% Downside
March 08, 2018 at 09:21 AM EST
Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Sangamo Therapeutics Inc (SGMO). The average 12-month price target for SGMO averaging the work of 6 analysts reveals an average price target of $23.50/share..
